报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 1.02% | -63.18% | -85.97% | 71/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
2024-12-31 | 7.27% | -17.76% | -10.02% | 48/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
2024-09-30 | 8.08% | -7.34% | 60% | 33/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 5.05% | 15.03% | 82.31% | 37/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 2.77% | 11.24% | -68.67% | 32/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 8.84% | -2.1% | 1.38% | 44/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 8.72% | -2.57% | 98.63% | 36/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 4.39% | -0.68% | 76.31% | 54/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 2.49% | -17.28% | -72.43% | 49/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 9.03% | -18.79% | 0.89% | 68/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 8.95% | -10.41% | 102.49% | 60/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 4.42% | -32.21% | 46.84% | 74/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 3.01% | -28.5% | -72.93% | 54/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 11.12% | -7.41% | 11.31% | 74/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 9.99% | 2% | 53.22% | 60/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 6.52% | 132.03% | 54.87% | 63/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 4.21% | 2% | -64.95% | 39/131 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 12.01% | -19.72% | 327.4% | 79/131 | 25.69% | 中红医疗 | 168% | 行业排名> |
2020-06-30 | 2.81% | 2% | -81.22% | 88/131 | 15.16% | 圣湘生物 | 112.46% | 行业排名> |
2019-12-31 | 14.96% | 2% | 2% | 57/131 | 14.38% | 博拓生物 | 108.13% | 行业排名> |